Urology Devices Market Size & Share, by Product (Dialysis, Endoscopes & Endovision Systems, Lasers & Lithotripsy, Consumables & Accessories, Urodynamic Systems, Biopsy Devices); Disease (Kidney Disease, Urological Cancer & BPH, Pelvic Organ Prolapse); Technology (Minimally Invasive, Robotic Surgery); End-user (Hospitals, Dialysis Centers, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4571
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Urology Devices Landscape

top-features-companies
    • Boston Scientific Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • KARL STORZ SE & Co. KG
    • Becton, Dickinson and Company (BD)
    • Richard Wolf GmbH
    • Intuitive Surgical, Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Olympus Corporation
    • Coloplast
    • Medtronic
    • Stryker Corporation

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • KARL STORZ SE & Co. KG has announced that its KARL STORZ HyDome has been selected for the Red Dot Award in the Product Design 2019 category based on of its outstanding design, quality, and functionality. Its duodenoscopy system combines a reusable endoscope for duodenal endoscopy and bile duct treatment with an innovative lever mechanism.

  • Boston Scientific Corporation has announced that the Federal Joint Committee (G-BA) has given a very positive benefit assessment of photoselective vaporization (PVP) for the treatment of benign prostatic syndrome (BPS).


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4571
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising prevalence of chronic kidney diseases (CKD), increasing prevalence of prostate cancer, upsurge in bladder cancer, and raise in urinary incontinence cases are some major factors driving the growth of the market.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023-2033.

High costs of urology devices, rising concerns about the risks associated with urologic surgeries, and stringent government rules for approval of novel treatment methods are estimated to hamper the market growth.

The market in the North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Boston Scientific Corporation, KARL STORZ SE & Co. KG, Becton, Dickinson and Company (BD), Richard Wolf GmbH, Intuitive Surgical, Inc., Fresenius Medical Care AG & Co. KGaA, Olympus Corporation, Coloplast, Medtronic, Stryker Corporation, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, disease, technology, end-user, and by region.

The kidney disease segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying